Alpha Teknova Inc. logo

Alpha Teknova Inc.

TKNO | NASDAQ
Chart Builder DCF Calculator
$8.79
+$0.45 (+5.40%)
Sep 22, 2026, 11:40 AM ET · Market open

Company Profile

Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.

Key Executives

Name Position
Stephen Gunstream President, Chief Executive Officer & Director
Matthew C. Lowell Chief Financial Officer
Damon A. Terrill General Counsel, Chief Compliance Officer & Secretary
Jennifer Henry Senior Vice President of Marketing

Latest SEC Filings

Date Type Title
Aug 06, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Jul 16, 2026 4 Filing
Jun 02, 2026 4 Filing
Jun 02, 2026 4 Filing
Jun 02, 2026 4 Filing
Jun 01, 2026 8-K Current Report
May 07, 2026 10-Q Quarterly Report
May 06, 2026 8-K Current Report
Apr 21, 2026 ARS Filing
View All SEC Filings
Alpha Teknova Inc.
Alpha Teknova Inc. logo
Country United States
IPO Date Jun 24, 2021
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 158
CEO Stephen Gunstream

Contact Details

2290 Bert Drive Hollister, California 95023 United States

Stock Details

Ticker Symbol TKNO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001850902
CUSIP Number 02080L102
ISIN Number US02080L1026
SIC Code 2835

© 2026 bestshares.com. All rights reserved.